{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:22:08Z","timestamp":1782739328134,"version":"3.54.5"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.det.2018.02.013","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T02:48:02Z","timestamp":1524710882000},"page":"267-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pruritus in Autoimmune Connective Tissue Diseases"],"prefix":"10.1016","volume":"36","author":[{"given":"Gideon P.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahya","family":"Argobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.det.2018.02.013_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2004.12.015","article-title":"Cutaneous symptoms of dermatomyositis significantly impact patients\u2019 quality of life","volume":"54","author":"Hundley","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2018.02.013_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2230.2004.01510.x","article-title":"Pruritus in adult dermatomyositis","volume":"29","author":"Shirani","year":"2004","journal-title":"Clin Exp Dermatol"},{"issue":"7","key":"10.1016\/j.det.2018.02.013_bib3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-4632.2011.05449.x","article-title":"A\u00a0comparative study of clinical characteristics, work-up, treatment, and association to malignancy in dermatomyositis between two tertiary skin centers in the USA and Singapore","volume":"52","author":"Yosipovitch","year":"2013","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.02.013_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jaad.2013.03.015","article-title":"Characterization of clinical photosensitivity in cutaneous lupus erythematosus","volume":"69","author":"Foering","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2018.02.013_bib5","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jaad.2010.10.016","article-title":"Quality of life in dermatomyositis","volume":"65","author":"Goreshi","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.det.2018.02.013_bib6","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archderm.138.9.1231","article-title":"Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus","volume":"138","author":"Pelle","year":"2002","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.02.013_bib7","first-page":"92","article-title":"Malignancy associated with dermatomyositis - a retrospective single-center study with 33 patients","volume":"38","author":"Travassos","year":"2013","journal-title":"Acta Reumatol Port"},{"issue":"7","key":"10.1016\/j.det.2018.02.013_bib8","first-page":"558","article-title":"Chronic pruritus in autoimmune dermatoses : results of a comparative survey","volume":"63","author":"Schroder","year":"2012","journal-title":"Hautarzt"},{"issue":"4","key":"10.1016\/j.det.2018.02.013_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archinte.1990.00390160099020","article-title":"Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences","volume":"150","author":"Ward","year":"1990","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.det.2018.02.013_bib10","first-page":"1474","article-title":"Manifestations and treatment of cutaneous lupus erythematosus (Part II of II)","volume":"10","author":"Schairer","year":"2011","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"10","key":"10.1016\/j.det.2018.02.013_bib11","first-page":"1212","article-title":"Manifestations and treatment of cutaneous lupus erythematosus (part I of II)","volume":"10","author":"Schairer","year":"2011","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"8","key":"10.1016\/j.det.2018.02.013_bib12","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/acr.21966","article-title":"Association of smoking with cutaneous manifestations in systemic lupus erythematosus","volume":"65","author":"Bourre-Tessier","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"10.1016\/j.det.2018.02.013_bib13","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/jid.2011.237","article-title":"Cigarette smoking and response to antimalarials in cutaneous lupus erythematosus patients: evolution of a dogma","volume":"131","author":"Dutz","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.det.2018.02.013_bib14","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/art.24538","article-title":"Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort","volume":"61","author":"Pons-Estel","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.det.2018.02.013_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/15569527.2010.521225","article-title":"Antimalarial cutaneous side effects: a study in 209 users","volume":"30","author":"Skare","year":"2011","journal-title":"Cutan Ocul Toxicol"},{"issue":"5","key":"10.1016\/j.det.2018.02.013_bib16","first-page":"586","article-title":"A\u00a0case of hydroxychloroquine induced pruritus","volume":"16","author":"Gul","year":"2006","journal-title":"Eur J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2018.02.013_bib17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/1529-0131(199804)41:4<744::AID-ART26>3.0.CO;2-F","article-title":"Antimalarial drug-induced aquagenic-type pruritus in patients with lupus","volume":"41","author":"Jimenez-Alonso","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.det.2018.02.013_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2340\/00015555-0867","article-title":"Itch in ethnic populations","volume":"90","author":"Tey","year":"2010","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.det.2018.02.013_bib19","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.cell.2009.11.034","article-title":"Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus","volume":"139","author":"Liu","year":"2009","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.det.2018.02.013_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/j.ajkd.2007.09.024","article-title":"Dermatological disease in patients with CKD","volume":"51","author":"Brewster","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"35","key":"10.1016\/j.det.2018.02.013_bib21","doi-asserted-by":"crossref","first-page":"12662","DOI":"10.3748\/wjg.v20.i35.12662","article-title":"Association of autoimmune hepatitis and systemic lupus erythematodes: a case series and review of the literature","volume":"20","author":"Beisel","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.det.2018.02.013_bib22","first-page":"889","article-title":"Primary sclerosing cholangitis occurring in a patient with systemic lupus erythematosus and diabetes mellitus","volume":"79","author":"Alberti-Flor","year":"1984","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.det.2018.02.013_bib23","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/bjd.14998","article-title":"Itch and systemic sclerosis: frequency, clinical characteristics and consequences","volume":"176","author":"Th\u00e9r\u00e9n\u00e9","year":"2017","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2018.02.013_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpainsymman.2015.12.314","article-title":"The impact of pain and itch on functioning and health-related quality of life in systemic sclerosis: an exploratory study","volume":"52","author":"Racine","year":"2016","journal-title":"J\u00a0Pain Symptom Manage"},{"issue":"11","key":"10.1016\/j.det.2018.02.013_bib25","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1093\/rheumatology\/ket275","article-title":"Prevalence and clinical correlates of pruritus in patients with systemic sclerosis: an updated analysis of 959 patients","volume":"52","author":"Razykov","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.det.2018.02.013_bib26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s40257-016-0201-9","article-title":"Chronic pruritus and connective tissue disorders: review, gaps, and future directions","volume":"17","author":"Haber","year":"2016","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"10.1016\/j.det.2018.02.013_bib27","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2340\/0001555565419423","article-title":"Dry hands in scleroderma. Including studies of sweat gland function in healthy individuals","volume":"65","author":"Serup","year":"1985","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.det.2018.02.013_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1529-8019.2012.01504.x","article-title":"Moisturizers: reality and the skin benefits","volume":"25","author":"Nolan","year":"2012","journal-title":"Dermatol Ther"},{"issue":"10","key":"10.1016\/j.det.2018.02.013_bib29","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.4049\/jimmunol.1302005","article-title":"Little peptide, big effects: the role of LL-37 in inflammation and autoimmune disease","volume":"191","author":"Kahlenberg","year":"2013","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.det.2018.02.013_bib30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1600-0625.2011.01327.x","article-title":"LL-37 suppresses sodium nitroprusside-induced apoptosis of systemic sclerosis dermal fibroblasts","volume":"20","author":"Kim","year":"2011","journal-title":"Exp Dermatol"},{"issue":"3","key":"10.1016\/j.det.2018.02.013_bib31","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2133.2006.07391.x","article-title":"Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma","volume":"155","author":"Kreuter","year":"2006","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.02.013_bib32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2340\/0001555576126128","article-title":"Occurrence and distribution of peptidergic nerve fibers in skin biopsies from patients with systemic sclerosis","volume":"76","author":"Wallengren","year":"1996","journal-title":"Acta Derm Venereol"},{"issue":"22","key":"10.1016\/j.det.2018.02.013_bib33","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1001\/jama.2013.282023","article-title":"Pruritus in the older patient: a clinical review","volume":"310","author":"Berger","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.det.2018.02.013_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40266-015-0246-0","article-title":"Chronic pruritus in the elderly: pathophysiology, diagnosis and management","volume":"32","author":"Valdes-Rodriguez","year":"2015","journal-title":"Drugs Aging"},{"issue":"5","key":"10.1016\/j.det.2018.02.013_bib35","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.canep.2013.04.014","article-title":"The risk of cancer development in systemic sclerosis: a meta-analysis","volume":"37","author":"Zhang","year":"2013","journal-title":"Cancer Epidemiol"},{"issue":"6","key":"10.1016\/j.det.2018.02.013_bib36","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s10067-016-3288-8","article-title":"Risk factors for malignancy in systemic sclerosis patients","volume":"35","author":"Ka\u015fifo\u011flu","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.det.2018.02.013_bib37","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/1346-8138.12827","article-title":"Association of anti RNA polymerase III antibody and malignancy in Japanese patients with systemic sclerosis","volume":"42","author":"Saigusa","year":"2015","journal-title":"J\u00a0Dermatol"},{"issue":"7","key":"10.1016\/j.det.2018.02.013_bib38","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3899\/jrheum.101144","article-title":"Malignancies in italian patients with systemic sclerosis positive for Anti-RNA polymerase III antibodies","volume":"38","author":"Air\u00f2","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.det.2018.02.013_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3899\/jrheum.160817","article-title":"Malignancies in patients with Anti-RNA Polymerase III antibodies and systemic sclerosis: analysis of the EULAR scleroderma trials and research cohort and possible recommendations for screening","volume":"44","author":"Lazzaroni","year":"2017","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.det.2018.02.013_bib40","doi-asserted-by":"crossref","first-page":"804296","DOI":"10.1155\/2011\/804296","article-title":"Low-dose naltrexone for pruritus in systemic sclerosis","volume":"2011","author":"Frech","year":"2011","journal-title":"Int J Rheumatol"},{"issue":"1","key":"10.1016\/j.det.2018.02.013_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0781.2008.00328.x","article-title":"Efficacy of UVA1 phototherapy in 230 patients with various skin diseases","volume":"24","author":"Rombold","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"5","key":"10.1016\/j.det.2018.02.013_bib42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1468-3083.2011.04137.x","article-title":"Low-dose UVA(1) phototherapy for scleroderma: what benefit can we expect?","volume":"26","author":"Pereira","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.det.2018.02.013_bib43","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaad.2008.07.042","article-title":"Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review","volume":"59","author":"Kroft","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2018.02.013_bib44","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2133.2008.08672.x","article-title":"UVA1 phototherapy is effective in darker skin: a review of 101 patients of Fitzpatrick skin types I-V","volume":"159","author":"Jacobe","year":"2008","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2018.02.013_bib45","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.sder.2011.05.002","article-title":"Management of itch in atopic dermatitis","volume":"30","author":"Hong","year":"2011","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.det.2018.02.013_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-200634","article-title":"Refractory pruritus in primary biliary cirrhosis","volume":"2013","author":"Pinheiro","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.det.2018.02.013_bib47","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ki.2013.454","article-title":"Uremic pruritus","volume":"87","author":"Mettang","year":"2014","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.det.2018.02.013_bib48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.sder.2011.05.001","article-title":"Pruritus: management algorithms and experimental therapies","volume":"30","author":"Steinhoff","year":"2011","journal-title":"Semin Cutan Med Surg"},{"issue":"9","key":"10.1016\/j.det.2018.02.013_bib49","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/rheumatology\/40.9.1038","article-title":"Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine","volume":"40","author":"Coleiro","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.det.2018.02.013_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ajo.2004.02.010","article-title":"Therapeutic effect of cevimeline on dry eye in patients with Sjogren's syndrome: a randomized, double-blind clinical study","volume":"138","author":"Ono","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.det.2018.02.013_bib51","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000131754","article-title":"Skin involvement in systemic autoimmune diseases","volume":"10","author":"Rashtak","year":"2008","journal-title":"Curr Dir Autoimmun"},{"issue":"3","key":"10.1016\/j.det.2018.02.013_bib52","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2340\/00015555-2524","article-title":"Chronic pruritus in primary sj\u00f6gren's syndrome: characteristics and effect on quality of life","volume":"97","author":"Valdes-Rodriguez","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.det.2018.02.013_bib53","first-page":"305","article-title":"The most common rheumatic diseases in patients with autoimmune liver disease in the Hospital Arzobispo Loayza from 2008 -2013, Lima, Peru","volume":"34","author":"Paredes Millan","year":"2014","journal-title":"Rev Gastroenterol Peru"},{"issue":"31","key":"10.1016\/j.det.2018.02.013_bib54","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.3748\/wjg.v19.i31.5131","article-title":"Connective tissue diseases in primary biliary cirrhosis: a population-based cohort study","volume":"19","author":"Wang","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.det.2018.02.013_bib55","first-page":"55","article-title":"Autoimmune cholangitis associated to IgG4 related sclerosing disease","volume":"41","author":"Frider","year":"2011","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"9","key":"10.1016\/j.det.2018.02.013_bib56","first-page":"615","article-title":"Management of pruritus in patients with cholestatic liver disease","volume":"7","author":"Levy","year":"2011","journal-title":"Gastroenterol Hepatol (N\u00a0Y)"},{"issue":"4","key":"10.1016\/j.det.2018.02.013_bib57","doi-asserted-by":"crossref","first-page":"351","DOI":"10.7861\/clinmedicine.15-4-351","article-title":"Drug treatment of pruritus in liver diseases","volume":"15","author":"Hegade","year":"2015","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.det.2018.02.013_bib58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2013.12.010","article-title":"Outcome measures for primary Sjogren's syndrome: a comprehensive review","volume":"51","author":"Seror","year":"2014","journal-title":"J\u00a0Autoimmun"},{"issue":"3","key":"10.1016\/j.det.2018.02.013_bib59","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.revmed.2010.08.022","article-title":"Small fibre neuropathy in primary Sjogren syndrome","volume":"32","author":"Fauchais","year":"2011","journal-title":"Rev Med Interne"},{"issue":"4","key":"10.1016\/j.det.2018.02.013_bib60","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3109\/s10165-009-0180-2","article-title":"Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren's syndrome","volume":"19","author":"Wakasugi","year":"2009","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.det.2018.02.013_bib61","doi-asserted-by":"crossref","first-page":"e1091","DOI":"10.1542\/peds.2012-2597","article-title":"Evidence of small-fiber polyneuropathy in unexplained, juvenile-onset, widespread pain syndromes","volume":"131","author":"Oaklander","year":"2013","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.det.2018.02.013_bib62","first-page":"1","article-title":"The maddening itch: an approach to chronic urticaria","volume":"24","author":"Viegas","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"6","key":"10.1016\/j.det.2018.02.013_bib63","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2013-203305","article-title":"Primary Sj\u00f6gren\u2019s syndrome and malignancy risk: a systematic review and meta-analysis","volume":"73","author":"Liang","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.det.2018.02.013_bib64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13045-017-0464-5","article-title":"Characterization and risk estimate of cancer in patients with primary Sj\u00f6gren syndrome","volume":"10","author":"Brito-Zer\u00f3n","year":"2017","journal-title":"J\u00a0Hematol Oncol"},{"issue":"2","key":"10.1016\/j.det.2018.02.013_bib65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7861\/clinmedicine.14-2-157","article-title":"A\u00a0retrospective study of long-term outcomes in 152 patients with primary Sj\u00f6gren\u2019s syndrome: 25-year experience","volume":"14","author":"Abrol","year":"2014","journal-title":"Clin Med (Lond)"},{"issue":"3","key":"10.1016\/j.det.2018.02.013_bib66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rdc.2005.04.011","article-title":"Other manifestations of mixed connective tissue disease","volume":"31","author":"Pope","year":"2005","journal-title":"Rheum Dis Clin North Am"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351830024X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351830024X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T08:48:12Z","timestamp":1693644492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386351830024X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S073386351830024X"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2018.02.013","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pruritus in Autoimmune Connective Tissue Diseases","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2018.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}